ATE454404T1 - Intrazelluläre antikörper - Google Patents

Intrazelluläre antikörper

Info

Publication number
ATE454404T1
ATE454404T1 AT03776984T AT03776984T ATE454404T1 AT E454404 T1 ATE454404 T1 AT E454404T1 AT 03776984 T AT03776984 T AT 03776984T AT 03776984 T AT03776984 T AT 03776984T AT E454404 T1 ATE454404 T1 AT E454404T1
Authority
AT
Austria
Prior art keywords
intracellular
molecule
immunoglobulin
target
domain
Prior art date
Application number
AT03776984T
Other languages
English (en)
Inventor
Terence Howard Rabbitts
Tomoyuki Tanaka
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Res Council filed Critical Medical Res Council
Application granted granted Critical
Publication of ATE454404T1 publication Critical patent/ATE454404T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT03776984T 2002-11-15 2003-11-14 Intrazelluläre antikörper ATE454404T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0226729.2A GB0226729D0 (en) 2002-11-15 2002-11-15 Intracellular antibodies
PCT/GB2003/004942 WO2004046185A2 (en) 2002-11-15 2003-11-14 Intracellular antibodies

Publications (1)

Publication Number Publication Date
ATE454404T1 true ATE454404T1 (de) 2010-01-15

Family

ID=9947935

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03776984T ATE454404T1 (de) 2002-11-15 2003-11-14 Intrazelluläre antikörper

Country Status (10)

Country Link
US (2) US20050272107A1 (de)
EP (1) EP1560853B1 (de)
JP (1) JP2006518188A (de)
AT (1) ATE454404T1 (de)
AU (1) AU2003286241A1 (de)
CA (1) CA2506124A1 (de)
DE (1) DE60330893D1 (de)
ES (1) ES2337570T3 (de)
GB (1) GB0226729D0 (de)
WO (1) WO2004046185A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004033485A2 (en) * 2002-10-09 2004-04-22 The Trustees Of Boston University Nucleic acid supported protein complementation
US20090029370A1 (en) * 2005-10-27 2009-01-29 Trustees Of Boston University Real time nucleic acid detection in vivo using protein complementation
US20090220942A1 (en) * 2005-10-27 2009-09-03 Natalia Broude Activated split-polypeptides and methods for their production and use
AU2007352344A1 (en) * 2006-10-27 2008-11-06 St. Jude Children's Research Hospital Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production
GB0911215D0 (en) 2009-06-29 2009-08-12 Univ Erasmus Medical Ct Gamma globin therapy
TWI450415B (zh) * 2010-03-23 2014-08-21 Lg Innotek Co Ltd 發光裝置、發光裝置封裝件及照明系統
GB201103631D0 (en) * 2011-03-03 2011-04-13 Univ Leeds Identification of candidate therapeutics
TWI591074B (zh) * 2011-12-05 2017-07-11 Ｘ 染色體有限公司 ＰＤＧＦ受體β結合多肽
JP6073038B2 (ja) 2012-08-22 2017-02-01 モガム バイオテクノロジー リサーチ インスティチュート 安定化された免疫グロブリン可変ドメイン選別方法及び選別されたドメインの応用
BR112015010911A2 (pt) 2012-11-16 2022-10-25 Transposagen Biopharmaceuticals Inc Enzimas específicas de sítio e métodos de uso
SG10201800800YA (en) 2013-05-06 2018-03-28 Scholar Rock Inc Compositions and methods for growth factor modulation
US20170107541A1 (en) * 2014-06-17 2017-04-20 Poseida Therapeutics, Inc. A method for directing proteins to specific loci in the genome and uses thereof
LT3209685T (lt) 2014-10-23 2019-08-26 Singh Molecular Medicine, Llc Antikūnai su vienu duomenu, nukreipti prieš viduląstelinius antigenus
US20170267784A1 (en) 2014-10-23 2017-09-21 Singh Molecular Medicine, Llc Single domain antibodies directed against intracellular antigens
US9879087B2 (en) 2014-11-12 2018-01-30 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
DK3218005T3 (da) 2014-11-12 2023-03-27 Seagen Inc Glycan-interagerende forbindelser og anvendelsesfremgangsmåder
AU2016278226B2 (en) 2015-06-17 2021-08-12 Poseida Therapeutics, Inc. Compositions and methods for directing proteins to specific loci in the genome
TWI746473B (zh) 2015-11-02 2021-11-21 美商辛分子醫藥有限公司 針對細胞內抗原之單域抗體
IL258768B2 (en) 2015-11-12 2023-11-01 Siamab Therapeutics Inc Compounds interacting with glycans and methods of use
JP6293829B2 (ja) * 2016-08-05 2018-03-14 モガム インスティチュート フォー バイオメディカル リサーチＭＯＧＡＭ Ｉｎｓｔｉｔｕｔｅ ｆｏｒ Ｂｉｏｍｅｄｉｃａｌ Ｒｅｓｅａｒｃｈ 安定化された免疫グロブリン可変ドメイン選別方法及び選別されたドメインの応用
WO2018094143A1 (en) 2016-11-17 2018-05-24 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
KR20240044544A (ko) 2017-03-03 2024-04-04 씨젠 인크. 글리칸-상호작용 화합물 및 사용 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919650A (en) * 1990-04-22 1999-07-06 Bristol-Myers Squibb Co. Method for inactivation of protein function
DK0859841T3 (da) * 1995-08-18 2002-09-09 Morphosys Ag Protein/(poly)peptidbiblioteker
GB2344886B (en) * 1999-03-10 2000-11-01 Medical Res Council Selection of intracellular immunoglobulins
AU2003219277A1 (en) * 2002-03-14 2003-09-29 Medical Research Council Intracellular antibodies
US6919650B2 (en) * 2002-05-31 2005-07-19 Ballard Power Systems Corporation Hybrid synchronization phase angle generation method

Also Published As

Publication number Publication date
WO2004046185A3 (en) 2004-09-23
AU2003286241A1 (en) 2004-06-15
US20050272107A1 (en) 2005-12-08
JP2006518188A (ja) 2006-08-10
DE60330893D1 (de) 2010-02-25
WO2004046185A2 (en) 2004-06-03
US20100143939A1 (en) 2010-06-10
ES2337570T3 (es) 2010-04-27
EP1560853A2 (de) 2005-08-10
CA2506124A1 (en) 2004-06-03
GB0226729D0 (en) 2002-12-24
EP1560853B1 (de) 2010-01-06

Similar Documents

Publication Publication Date Title
ATE454404T1 (de) Intrazelluläre antikörper
Luchini et al. Protein painting reveals solvent-excluded drug targets hidden within native protein–protein interfaces
ATE391174T1 (de) Modifizierter tpo-agonisten antikörper
CY1109536T1 (el) Βελτιωμενες fc πρωτεϊνες συντηξης
DK1697421T3 (da) Bispecifikke antistoffer
MX2020000435A (es) Anticuerpos anti-cd166 y usos de estos.
CY1113400T1 (el) Αλλαγη των συγγενειων συνδεσης me fcrn ή των ημιζωων ορου αντισωματων με μεταλλαξιγενεση
ATE397661T1 (de) Bindungsdomänen des delta-proteins
EA200300362A1 (ru) Способ генерирования молекулярно-функциональной сети
EP1864998A3 (de) Bindungsmoleküle
BR0316384A (pt) Imunoensaio não competitivo para analitos pequenos
DK0906426T3 (da) Antistoffer mod ED-B-domænet af fibronektin, deres konstruktion og anvendelser
DE60222816D1 (de) Identifizierung hochaffiner moleküle durch screening mit begrenzter verdünnung
ATE476989T1 (de) Humanisierter monoklonaler antikörper gegen von- willebrand faktor
ATE365324T1 (de) Nachweis durch serrs in mikrofluidischer umgebung
ATE443318T1 (de) Audiosignalsynthese
EE200300092A (et) EDb-fibronektiinidomeeni retseptor
DE69530432T2 (de) Monoklonaler Antikörper gegen den Thrombin-Antithrombin Komplex-III und dessen Verwendung in immunoassays
DK1086135T3 (da) Monoklonalt antistof og assay til detektering af N-terminalt prokollagen (III)-propeptid (PIIINP)
MX2010004097A (es) Complejos de los dominios de trpc y sestd1 y metodos y usos que implican los mismos.
DK1651665T3 (da) Fremgangsmåde til oprensning af et ikke-immunglobulin-protein omfattende et immunglobulinlignende (Ig-lignende) domæne
DK1317564T3 (da) Screeningsfremgangsmåder til at identificere G-proteiner og andre forbindelser, som modulerer phosphodiesterase (PDE)-aktiviteten
Ritco‐Vonsovici et al. Molecular plasticity of β‐catenin: New insights from single‐molecule measurements and MD simulation
ATE532074T1 (de) Auf multi-immunoaffinität basierende indentifizierung von antigenen
Weser et al. Detection of TAP-tagged proteins in Western blot, confocal laser scanning microscopy and FACS using the ZZ-domain

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties